CDK6/9-IN-1

Modify Date: 2024-01-09 14:29:35

CDK6/9-IN-1 Structure
CDK6/9-IN-1 structure
Common Name CDK6/9-IN-1
CAS Number 2414373-55-8 Molecular Weight 452.94
Density N/A Boiling Point N/A
Molecular Formula C22H25ClN8O Melting Point N/A
MSDS N/A Flash Point N/A

 Use of CDK6/9-IN-1


CDK6/9-IN-1 (compound 66) is an oral available and dual CDK 6 and CDK 9 inhibitor, with IC50 values of 40.5 nM and 39.5 nM for CDK6 anmd CDK9, respectively[1].

 Names

Name CDK6/9-IN-1

 CDK6/9-IN-1 Biological Activity

Description CDK6/9-IN-1 (compound 66) is an oral available and dual CDK 6 and CDK 9 inhibitor, with IC50 values of 40.5 nM and 39.5 nM for CDK6 anmd CDK9, respectively[1].
Related Catalog
Target

CDK6:40.5 nM (IC50)

CDK9:39.5 nM (IC50)

In Vitro CDK6/9-IN-1 (compound 66, 4 or 8 μM in MDA-MB-231 cells) treatment induces G0/G1 cell cycle arrest (71.85% and 77.51%, respectively), when compared with the control (57.65%)[1].
In Vivo CDK6/9-IN-1 (compound 66) significantly inhibits tumor growth in an xenograft mouse model with no obvious toxicity, indicating the promising therapeutic potential of CDK6/9 dual inhibitors for cancer treatment[1].
References

[1]. Yang Wang, et al. Discovery and SARs of 5-Chloro- N4-phenyl- N2-(pyridin-2-yl)pyrimidine-2,4-diamine Derivatives as Oral Available and Dual CDK 6 and 9 Inhibitors With Potent Antitumor Activity. J Med Chem. 2020 Mar 26;63(6):3327-3347.

 Chemical & Physical Properties

Molecular Formula C22H25ClN8O
Molecular Weight 452.94